Parametric Portfolio Associates’s Passage Bio PASG Stock Holding History

Parametric Portfolio Associates’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$89K	Buy	1,438 +383	+36%	+$31.6K	﹤0.01%	3580
2021 Q4	$134K	Buy	+1,055	New	+$172K	﹤0.01%	3508
2021 Q3	–	Sell	-1,884	Closed	-$499K	–	3643
2021 Q2	$499K	Buy	1,884 +617	+49%	+$191K	﹤0.01%	3086
2021 Q1	$443K	Buy	1,267 +341	+37%	+$146K	﹤0.01%	3558
2020 Q4	$474K	Sell	926 -136	-13%	-$54.5K	﹤0.01%	3410
2020 Q3	$278K	Buy	+1,062	New	+$365K	﹤0.01%	3519

Other funds holding PASG

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Highline Capital Management New York $51.6M AUM 21.72% 1-Year Est. Return

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return